PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan; National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, 852-8521, Japan. Electronic address: ysakurai@nagasaki-u.ac.jp.\', \'Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan.\', \'Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan; National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, 852-8521, Japan.\', \'Department of Molecular Infection Dynamics, Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan.\', \'Department of Molecular Infection Dynamics, Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, 852-8523, Japan.\', \'Pharmaceutical Research Department, Global Pharmaceutical R&D Division, Neopharma Japan Co., Ltd, Tokyo, 102-0071, Japan.\', \'School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, 852-8523, Japan; Department of Host - Defense Biochemistry, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan. Electronic address: kitak@nagasaki-u.ac.jp.\', \'Department of Virology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan. Electronic address: moritak@nagasaki-u.ac.jp.\', \'Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, 852-8523, Japan; National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, 852-8521, Japan. Electronic address: j-yasuda@nagasaki-u.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(21)00156-X10.1016/j.bbrc.2021.01.091
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 33571909
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
?:title
  • 5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33571909>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33571909>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all